Showing results (691-700 of 5,983) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|July 5, 2018
Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug EfficacyTatiana Lepikhova, Piia-Riitta Karhemo, Riku Louhimo, et al.
Molecular Cancer Therapeutics|July 13, 2018
Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress ResponseKathleen I Pishas, Christina D Drenberg, Cenny Taslim, et al.
Molecular Cancer Therapeutics|May 5, 2017
Modeling of Patient-Derived Xenografts in Colorectal CancerAnastasia Katsiampoura, Kanwal Raghav, Zhi-Qin Jiang, et al.
Molecular Cancer Therapeutics|May 5, 2017
Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease BiologyHatim Husain, David Nykin, Nam Bui, et al.
Molecular Cancer Therapeutics|September 28, 2016
Novel ABCG2 Antagonists Reverse Topotecan-Mediated Chemotherapeutic Resistance in Ovarian Carcinoma XenograftsJerec W Ricci, Debbie M Lovato, Virginia Severns, et al.
Molecular Cancer Therapeutics|September 18, 2016
Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian CancerYan Huang, Lenard M Lichtenberger, Morgan Taylor, et al.
Molecular Cancer Therapeutics|September 2, 2016
Macrophage Susceptibility to Emactuzumab (RG7155) TreatmentLeon P Pradel, Chia-Huey Ooi, Solange Romagnoli, et al.
Molecular Cancer Therapeutics|September 2, 2016
RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor ModelsPavel Strop, Thomas-Toan Tran, Magdalena Dorywalska, et al.
Molecular Cancer Therapeutics|April 28, 2017
Ref-1/APE1 as a Transcriptional Regulator and Novel Therapeutic Target in Pediatric T-cell LeukemiaJixin Ding, Melissa L Fishel, April M Reed, et al.
Pageof 599